108 results on '"Bannert, B"'
Search Results
2. Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz von Biologikatherapien nach Versagen konventioneller Therapien bei Patienten mit entzündlich rheumatischen Erkrankungen: Ergebnisse eines nationalen Registers (GRAID2)
3. POS0516 PERFORMANCE OF NURSE-LED GOUT CARE IN A PRIVATE HEALTHCARE SYSTEM. A RANDOMISED CONTROLLED TRIAL
4. Brauchen wir noch klinische Studien in der Rheumatologie?
5. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
6. POS0107 ACPA POSITIVITY DETERMINES REMISSION IN PATIENTS WITH RA TREATED WITH IV AND SC ABATACEPT: A POST HOC ANALYSIS OF THE REAL-WORLD OBSERVATIONAL ACTION AND ASCORE STUDIES
7. POS0512 ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS DETERMINES 2-YEAR RETENTION OF IV AND SC ABATACEPT IN PATIENTS WITH RA IN A REAL-WORLD SETTING
8. POS0268 INTRAVENOUS TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS: A PHASE IB DOSE-RANGING PHARMACOKINETIC BRIDGING STUDY
9. Impact du statut sérologique du facteur rhumatoïde (FR) et des anticorps anti-protéines citrullinées (ACPA) sur le maintien thérapeutique de l’abatacept (ABA) à 2 ans chez des patients (pts) atteints de polyarthrite rhumatoïde (PR)
10. Recognition of Cyclic Transmission of Sarcocystis stehlinii n. sp. in the Gran Canarian Giant Lizard
11. POS0447 PHYSICAL FUNCTION IN PATIENTS WITH RA, STRATIFIED BY SEROSTATUS AND TREATMENT LINE, FOLLOWING SC ABATACEPT: POST HOC ANALYSIS OF AN OBSERVATIONAL, 2-YEAR STUDY CONDUCTED IN ROUTINE CLINICAL PRACTICE (ASCORE)
12. POS0599 DISEASE ACTIVITY IN PATIENTS WITH RA BY SEROSTATUS AND TREATMENT LINE, FOLLOWING TREATMENT WITH ABATACEPT: RESULTS FROM AN INTERNATIONAL OBSERVATIONAL STUDY
13. AB0207 ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTING
14. OP0180 IMPACT OF RF AND ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS ON 2-YEAR RETENTION OF ABATACEPT IN PATIENTS WITH RA
15. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study
16. A structured concept to increase registration of clinical studies at the University Hospital Basel (USB) - An overview and comparison with other Swiss University Hospitals
17. Life cycle and parasitic interaction of the lizard-parasitizing mite Ophionyssus galloticolus (Acari: Gamasida: Macronyssidae), with remarks about the evolutionary consequences of parasitism in mites
18. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
19. Sarcocystis simonyi sp. nov. (Apicomplexa: Sarcocystidae) from the endangered Hierro giant lizardGallotia simonyi (Reptilia: Lacertidae)
20. Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz von Biologikatherapien nach Versagen konventioneller Therapien bei Patienten mit entzündlich rheumatischen Erkrankungen
21. In vitro und in vivo Effekte einer Therapie mit Tofacitinib auf humane B-Zellen
22. Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis (PreCePRA) by functional MRI of the Brain – an Interim Analysis of an ongoing Investigator initiated Phase III Trial
23. DEKAVIL (F8IL10): A novel therapeutic approach for the treatment of rheumatoid arthritis
24. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials
25. Safety, tolerabilty an initial signs of effecacy of the full human immunocytokine dekavil (F8IL10) : an novel therapeutic approach for rheumatoid arthriris
26. THU0040 Enhancement of early human b cell development by jak inhibition
27. Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz von Biologikatherapien nach Versagen konventioneller Therapien bei Patienten mit entzündlich rheumatischen Erkrankungen
28. THU0105 Prediction of response to CERTOLIZUMAB-PEGOL in rheumatoid arthritis (PRECEPRA) by functional MRI of the brain – an interim analysis of an ongoing investigator initiated phase III trial
29. Do we still need clinical studies in rheumatology?
30. Studienergebnisse der Inter-SpA: Sensitivität und Spezifität von IgA-anti-CD74 bei früher axialer Spondyloarthritis (axSpA)
31. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
32. THU0414 Inter SPA: Sensitivity and Specifity of Autoantibodies against CD74 in Early Axial Spondyloarthritis
33. THU0183 Treatment with Tofacitinib Inhibits Human Naïve B Lymphocyte Development and Function In Vitro
34. Use Effects on the Reflection of Macro Textured Surfaces
35. Brauchen wir noch klinische Studien in der Rheumatologie?
36. Cannibalism and autotomy as predator-prey relationship for monoxenous sarcosporidia
37. A NOVEL TLR7/8 ANTAGONIST BLOCKS PROINFLAMMATORY FUNCTION OF IMMUNE COMPLEXES FROM LUPUS PATIENTS AND ABROGATES LUPUSLIKE DISEASE IN MICE.
38. PERFORMANCE OF NURSE-LED GOUT CARE IN A PRIVATE HEALTHCARE SYSTEM. A RANDOMISED CONTROLLED TRIAL.
39. Causes and risk factors for death in systemic sclerosis – A study from the EULAR Scleroderma Trials And Research (EUSTAR) data base
40. Causes and risk factors for death in systemic sclerosis. A study from the EULAR Scleroderma Trials And Research (EUSTAR) data base
41. Causes of death in systemic sclerosis – A report from the EUSTAR data base
42. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
43. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
44. Real time-Monitoring und Therapie-Prozess-Steuerung stationärer Adipositas-Behandlung
45. Zeitabhängige Effektstärken stationärer Therapie bei Adipositas-Patienten mit psychischer Komorbidität
46. Das „Schwere-los“-Programm – ein multimodales Therapieprogramm zur stationären Behandlung adipöser Erwachsener
47. Real time-Monitoring stationärer Adipositas-Behandlung
48. New Eimeriid Coccidia from the Canarian Lizard, Gallotia galloti Oudart, 1839.
49. Sarcocystis simonyi sp. nov. (Apicomplexa: Sarcocystidae) from the endangered Hierro giant lizard Gallotia simonyi (Reptilia: Lacertidae).
50. Eimeria tarentolae n. sp. from the Moorish Gecko, Tarentola mauritanica.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.